ConductScience.org, home

Comparison · NCT04625283-5930766b

Ketamine vs Saline: Number of Participants Who Experienced ICU Transfer

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Ketamine vs Saline: Number of Participants Who Experienced ICU Transfer. Trial comparisons, record NCT04625283-5930766b. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04625283-5930766b

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.05710.04280.0758wilson
Risk in group 20.02930.01940.0439wilson
Risk difference, group 1 minus group 20.02790.007420.049newcombe hybrid score
Risk ratio, group 1 over group 21.951.183.23log
Odds ratio, group 1 over group 22.011.193.39log
Number needed to treat, for one more participant with the outcome on Ketamine than on Saline35.920.4135from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Ketamine
Participants in this arm will receive intraoperative ketamine bolus (0.5mg/kg) followed by continuous infusion 5 mcg/kg/min and also will receive postoperative ketamine infusion (2.5 mcg/kg/min, up to 100kg max) for 48 hours.~Ketamine: Participants in the ketamine arm will receive intraoperative and postoperative ketamine.
44770OG000
Group 2Saline
Participants in this arm will receive an equivalent volume of intraoperative saline bolus followed by continuous saline infusion and also will receive postoperative saline infusion for 48 hours.~Placebo: Participants in the placebo arm will receive intraoperative and postoperative saline.
22752OG001

Outcome

Type
SECONDARY
Title
Number of Participants Who Experienced ICU Transfer
Description
Number of participants who experienced transfer to ICU. This is as a binary outcome
Time frame
From hospital admission until discharge, typically 3-5 days
Population

Source ClinicalTrials.gov

Trial

Title
The Impact of Perioperative Ketamine Infusion on Surgical Recovery
NCT number
NCT04625283
Phases
PHASE4
Conditions
Opioid Use, Enhanced Recovery After Surgery, Anesthesia, Ketamine, Pain, Postoperative
Interventions
Ketamine, Placebo
Lead sponsor
Vanderbilt University Medical Center
Results first posted
2025-02-04

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04625283-5930766b